New Zealand King Salmon Investments Limited logo

NZK 1H21 Half Year Results Announcement

Half Year Results23 February 2021NZKConsumer Staples

Market Announcement
February 24, 2021

NEW ZEALAND KING SALMON ANNOUNCES 1H21 RESULT

New Zealand King Salmon Investments Ltd (NZX & ASX:NZK) reports its financial performance for the

six month period ended 31 December 2020 (1H21). Key points include:

• Covid-19 disruptions to both domestic and export markets have impacted profitability.

• Mitigation strategies include a global rebalancing of sales towards retail and the prioritisation

of premium customer opportunities.

• Clearing excess inventory with retail price promotions and selective foodservice sales

impacted margins but did improve cashflow.

• Average price achieved of $23.90/kg, slightly down from $24.46/kg in 1H20.

• Revenue of $82.4m, down from $84.2m in 1H20, reflecting lower average pricing.

• Sales volume of 3,441 tonnes was equal to 1H20.

• Pro Forma Operating EBITDA of $10.5m, compared with $16.5m in 1H20.

• Statutory NPAT of ($4.3m), down from $20.8m in 1H20.

• No interim dividend is declared.

Chairman John Ryder said: “Despite a challenging year with the Covid-19 pandemic still affecting our

business, sales volumes in the six months were almost identical to the previous year. This result is

encouraging considering the ongoing restrictions on foodservice, particularly in the US and Europe.

“Re-establishing our global sales incurred higher costs with expensive air freight being a significant

factor.

“In the US, it’s excellent to see our Ōra King salmon now being sold via new channels, including

speciality seafood online, and an increased retail presence for our Regal smoked salmon. In addition

to premium branded sales recovering, we believe we have sufficient indications of positive demand

to ensure clearance of all surplus fish by around mid CY21.”

New Zealand King Salmon CEO Grant Rosewarne acknowledged it had been a tough period following

the continued impact of the lockdown but anticipates that sales demand will again be greater than

the company’s ability to supply later in the year.

“Necessary changes to our sales strategies have impacted profitability and this has increased our

determination to build resilience through channel, category and geographic diversity. Core sales have

recovered better than expected – now we need to rebuild value.

“We have already paved the way for incremental demand by keeping our premium brands prominent

in the mind of the consumer. In New Zealand, for example, we have chosen to promote our new Regal

Maple range to encourage trial, grow the market and build Regal brand awareness. Customers around

the world are still eager for our King salmon products which fit well into the growing global demand

for healthy and safe food products.

“We continue to evolve our aquaculture model with upwelling being used on the farms where we

have seen warmer water temperatures, particularly on lower flow sites.


“We’re optimistic that our plans to farm in the open ocean, 7kms north of Cape Lambert in the Cook

Strait are progressing well. Our Blue Endeavour application is now expected to have a hearing in

July/August this year. If successful, we would expect a harvest in mid CY24.”

The application is aligned with the Government’s Aquaculture Strategy which was launched in late

2019 with the objective to have the industry achieve $3 billion by 2035.

“Blue Endeavour will play a critical role in our future with climate change continuing to impact our

farms.

“It’s undoubtedly an exciting time for the industry as the future for salmon farming is in the open

ocean. We will need the continued support from all levels of Government and the community to

achieve it. We firmly believe that Aquaculture could become New Zealand’s most valuable industry

and its greenest primary sector” Mr Rosewarne added.

Following the change in the company’s balance date to 31 January, further information on the outlook

will be provided at the full year results announcement at the end of March.


Ends


Contact: Grant Rosewarne

Managing Director and CEO, New Zealand King Salmon Investments Ltd.

Email: grant.rosewarne@kingsalmon.co.nz




About New Zealand King Salmon

New Zealand King Salmon is the world’s largest producer of the premium King salmon species. We

operate under four key brands: Ora King, Regal, Southern Ocean and Omega Plus, and the New

Zealand King Salmon label. We have been growing and selling salmon to consumers for more than 30

years. Today we employ over 500 people. New Zealand investors make up a significant percentage of

the ownership of NZ King Salmon, and the communities of Marlborough, Nelson and Tasman are well

represented with around 400 of the approximately 2,900 shareholders being from the Top of the

South.


More information can be found at www.kingsalmon.co.nz

---

1H21 HALF YEAR FINANCIAL RESULTS

1H21 HALF YEAR RESULTS
HIGHLIGHTS

2

01

1H21 HALF YEAR RESULTS
1H21 SUMMARY

Profitability impacted by COVID-19. These impacts are expected to be temporary:

•Profitability impacted by early calendar year 2020 sales disruption and its flow on impacts:

►Higher airfreight costs.

►Requirement to move excess inventories built up during lockdown – an industry-wide issue.

►Higher than usual domestic retail promotional activity to stimulate sales.

•Pro Forma Operating EBITDA of $10.5m, compared with $16.5m in 1H20. Proforma NPAT of $3.7m, compared with $8.7m in 1H20.

•Statutory NPAT of ($4.3m), compared with $20.8m in 1H20.

•Imported Atlantic programme now margin positive.

3

* A full reconciliation between GAAP and Pro Forma results is shown on pages 19 and 20 of this presentation.

1H21 HALF YEAR RESULTS
1H21 SUMMARY (CONTINUED)

Strong domestic and international recovery in sales:

•Sales volumes 3,442 MT are consistent with sales during 1H20 (prior to onset of the COVID pandemic) of 3,441 MT.

•Branded product has retained its premium positioning and pricing both domestically and offshore.

•Development of new sales channels in North America resulted in sales volume growth in this market and positions the business well for accelerated

growth as foodservice markets return to strength.

•Strong growth in domestic retail sales with launch of new ‘maple’ hot and cold smoked products. Our TV and promotional activityled to smoked

category growth of 11% year-on-year with NZKS share increasing from 49% to 56%.

•Sales of $82.3m only 2% down on pre-pandemic 1H20 levels ($84.2m).

•Successful June Hog (7kg+ ŌraKing) trial with US customers. Strong example of further product differentiation

and value creation within the product range.

Outlook

•We will make further comment on New Zealand King Salmon’s outlook when FY21 full year results are provided

to the market (end of March)

•We expect all excess inventories of salmon to be cleared by the middle of calendar year 2021.

•Demand anticipated to exceed supply from late calendar year 2021.

4

Margin ($ per KG)

Ōra King

(3-7 kgs)

June Hog

(7+ kgs)

Tyee

(12+ kgs)

1H21 HALF YEAR RESULTS
GEOGRAPHIC SPREAD

OF REVENUE

FACTS AND FIGURES

36%

4%

4%

45%

7%

3%

$82.3

1H21 REVENUE OF

MILLION

4,150

METRIC TONNES HARVESTED

DURING 1H21

5

7.3

19.5

17.3

16.5

10.5

-

5

10

15

20

25

1H171H181H191H201H21

NZ$m

1H PRO-FORMA OPERATING EBITDA

8.7

15.7

15.1

20.8

(4.3)

(10)

(5)

-

5

10

15

20

25

1H171H181H191H201H21

NZ$m

1H STATUTORY NPAT

1%

1H21 HALF YEAR RESULTS
FINANCIAL

OVERVIEW

6

0302

1H21 HALF YEAR RESULTS
•Performance recovering as new sales channels are developed resulting in total sales volumes consistent with same time a

year ago (prior to COVID sales disruption). Some excess inventory cleared at lower prices.

•GAAP results are impacted by fair value losses, a function of tighter margins during 1H21. In addition, the mix of livestock

sees a larger proportion of younger fish in the water.

SUMMARY FINANCIAL INFORMATION

* A full reconciliation between GAAP and Pro Forma results is shown on pages 19 and 20 of this presentation.

7

Group Financial Performance

NZ$000s1H211H20% chg.1H211H20% chg.

Volume Sold (MT)3,4423,4410%3,4423,4410%

Revenue82,27984,189-2%82,27984,189-2%

Gross Margin24,57330,857-20%14,34347,886-70%

Gross Margin %30%37%17%57%

EBITDA10,50416,470-36%27433,946-99%

EBITDA %13%20%0%40%

EBIT6,24112,695-51%(4,729)29,515-116%

NPAT3,6608,722-58%(4,323)20,766-121%

Pro-Forma*GAAP

1H21 HALF YEAR RESULTS
FarmVolume Harvested*

1H202H201H21

Queen Charlotte

Ruakaka480 MT--

Otanerau--910 MT

Tory Channel

Clay Point565 MT1,535 MT-

Te Pangu690 MT1,510 MT1,360 MT

Ngamahau490 MT540 MT-

Pelorus Sound

Waitata1,520 MT-35 MT

Kōpaua---

Waihinau--830 MT

Forsyth--1,010 MT

3,745 MT3,585 MT4,145 MT

Total harvest was up to 4,150 MT. The new production model sees a slightly higher proportion of harvest taking place in the

Pelorus and Queen Charlotte sounds during FY21.

HARVEST BY FARM

8

*Based on harvests from sea farms. Note that minor additional volumes are harvested from our hatcheries (a total of 6 MT in FY20 and 5 MT in 1H21).

1H21 HALF YEAR RESULTS
New Zealand King Salmon maintains its strong financial position.

Our balance sheet remains strong with debt increasing due to higher inventories:

•Net debt of $43.0m (out of total debt facilities of $65.0m):

►We remain confident we have the funding facilities and bank support in place to

navigate this period.

►Above average inventories expected to be converted to cash in the near future

following strong recovery in sales.

►No issues with customer collections, increases in Receivables reflects improving sales.

►Given the uncertain macroeconomic climate, the Board does not expect to declare a

dividend for the 7 month FY21 year.

•PP&E largely stable with capex slowed to an annual run-rate of ~$10m. Total capex for

the 7 month FY21 year is ~$5.4m.

•‘Other’ current and non-current assets increased by >$15m due increases in the mark-to-

market valuation of foreign exchange contracts.

BALANCE SHEET

9

Group Financial Position

Dec-20

Jun-20

NZ$000sUnaudited

Audited

Current Assets

Cash and equivalents

5,5817,115

Receivables14,75812,777

Inventories45,78335,612

Biological Assets

69,67781,784

Other

5,734907

141,533

138,195

Non-current Assets

Property, plant & equipment60,908

60,481

Right of use assets7,039

4,581

Biological assets

18,22610,594

Other70,859

60,333

157,032135,989

Total Assets298,565274,184

Current Liabilities

Loans (external)(2,614)(1,132)

Lease Liabilities(1,586)(1,347)

Payables(17,469)(14,847)

Other(10,646)(10,767)

(32,315)(28,093)

Non-Current Liabilities

Loans (external)(46,000)(37,000)

Lease Liabilities(5,544)(3,258)

Other(20,291)(21,519)

(71,835)(61,777)

Total Liabilities(104,150)(89,870)

Net Assets194,415184,314

Net Cash / (Debt)(43,033)(31,017)

1H21 HALF YEAR RESULTS
OPERATIONAL UPDATE

10

03

1H21 HALF YEAR RESULTS
JanFebMarAprMayJunJulAugSepOctNovDec

20192020

SALES PERFORMANCE

Sale volumes have been rebuilt, with volumes of product sold in November and December 2020 higher than the same period

in 2019:

•A strong recovery in sales volumes particularly during Q4 calendar year 2020, albeit with temporary margin compression.

•Growth in domestic retail coupled with strong sales in the US as new channels to market are developed has replaced COVID-affected foodservice market.

•Our sales model has become more resilient. Increased sales depth positions the business well for sales during the 2021 calendaryear.

Trends in volumes show a strong recovery in sales, especially in the last 3 months of 2020

11

Total Sales Volumes by Month, 2020 vs 2019 (MT)

Global lockdowns

AklLvl3

lockdown

NZ retail

promotions

1H21 HALF YEAR RESULTS
12

SALES BY MARKET - EXPORT

Sales to North America have recovered strongly as alternative channels to market

have been developed

•Record volume of product sold to North America whilst maintaining price in a challenging environment

(except for discrete disposal sales at a lower price).

•We have cultivated new sales channels for our product in North America to fill the gap left behind by

foodservice due to COVID lockdowns. This includes online delivery, fishmongers and specialty retail.

•Successful trial of ŌraKing June Hog in US.

•Post COVID, these new channels should provide the platform for an acceleration of growth in this

market.

Continuing to target branded premium markets

North America (MT)

China (MT)

Sales to China have decreased through the

pandemic

•Sales to this market continue to be affected by global

challenges.

•Sales are not expected to increase during this period.

•Petfood sales (not shown) growing strongly.

682

1,158

1,173

1,227

1,230

1,036

1,017

1,204

1,088

FY17FY18FY19FY201H21

25

46

80

17

23

46

104

46

FY17FY18FY19FY201H21

First half salesSecond half sales

1H21 HALF YEAR RESULTS
13

SALES BY MARKET - EXPORT

Strong performance in other export markets

Most markets saw an increase in volumes, premium branded product maintained solid price performance

•Australia – a positive result with sales growth as NZKS continues to establish its premium positioning in foodservice markets.

•Asia (ex Japan and China) – this market continues to track well but has been impacted in the short-term by the loss of airline customers.

•Japan – excess frozen volumes cleared through Japan resulting in increased volumes to this market but with margins temporarily impacted.

•Europe – strong and pleasing growth in sales to Europe, as increased resources in this market have delivered record sales volumes for this region.

Australia (MT)Asia (MT)

Excludes Japan and China

Japan (MT)Europe (MT)

First half salesSecond half sales

369

349

291

216

236

334

235

253

173

FY17FY18FY19FY201H21

152

201

207

194

137

160

208

226

159

FY17FY18FY19FY201H21

146

310

117

135

203

185

132

132

99

FY17FY18FY19FY201H21

43

55

73

67

94

45

66

54

53

FY17FY18FY19FY201H21

1H21 HALF YEAR RESULTS
14

SALES BY MARKET - DOMESTIC

Growth in retail volumes as emphasis placed on smoked products

•Disruption to export and foodservice markets has created the opportunity to renew domestic retail

interest, grow the market, and build brand awareness.

•NZKS has targeted demand growth in smoked products including through the launch of new

‘maple’ smoked products.

•These initiatives, coupled with promotional activity and increased marketing spend have delivered a

14% year-on-year growth in domestic retail sales (by volume), offsetting contraction in the COVID-

impacted foodservice market.

•Margins have temporarily declined as a result of initiatives to support sales growth.

Strong growth in retail offsets COVID impacted foodservice market

Domestic Market(MT)

First half salesSecond half sales

2,039

2,294

1,915

1,522

1,525

2,008

1,682

1,725

1,272

FY17FY18FY19FY201H21

1H21 HALF YEAR RESULTS
AVERAGE SALE PRICES

New Zealand King Salmon’s core branded and differentiated business continues to attract premium pricing. Pricing for

these products has remained firm.

Excess product (due to the significant supply and demand imbalance in and around April / May 2020) has resulted in some frozen product being sold in

Japan and the US at lower pricing. Initiatives are in place to have all excess stock cleared by the middle of calendar year 2021.

Branding underpins customer loyalty and value to our business

15

* Volume weighted average sales price for all exported salmon based on foreign exchange rates achieved as outlined on the table above.

Sale Prices* and Exchange Rates

FY17FY18FY19FY201H21

Average Sales Price per kg

Domestic SalesNZD18.77 20.22 22.11 24.91 24.31

Export Sales (All Markets)NZD20.46 21.70 23.85 25.05 24.36

Foreign Exchange Rates

NZD:AUD0.930.930.940.940.94

NZD:USD0.690.690.680.670.64

NZD:JPY77.175.671.368.369.1

1H21 HALF YEAR RESULTS
16

FISH PERFORMANCE

Fish performance continues to be a key focus for the business

•New Aquaculture General Manager, Grant Lovell (20 years King Salmon experience), is combining the best of prior production models.

•Harvest volumes increased to 4,150 MT, 11% higher than 1H20.

•Harvest rates were intentionally slowed through Q4 FY20 before being accelerated recently to manage summer biomass levels. This led to larger and

older fish and inevitably higher levels of mortality due to fish maturation (estimated at 30% of 1H21 total mortality). In addition these larger and

older fish display poorer levels of feed conversion. Accordingly, the impact of fish performance initiatives has yet to be reflected in these results.

•We continue to adapt our operating model to mitigate the impact of warmer summer waters. Upwelling is being used this summertocirculate

cooler deeper water to our fish especially at low flow sites.

•Biomass at sea is consistent with levels in recent periods.

Biological Performance

1H211H20% chg.1H19% chg.

Harvest Volume (MT)4,150 3,742 11%4,026 3%

Feed Conversion Ratio (FCR)1.731.598%1.74-1%

Mortality as a % of Biomass11.9%5.6%113%5.6%114%

Closing Livestock Biomass6,944 7,060 -2%6,915 0%

Feed Cost ($ / Kg of feed)2.542.483%2.444%

1H21 HALF YEAR RESULTS
FUTURE FARMING & HARVEST VOLUMES

17

This slide provides an update on future farming volumes:

Farm relocation (MPI Salmon Relocation Process):

•Adoption of the 2017 Panel recommendation would be unlikely to have any material impact on site capacity however it may result in modest fish

performance improvements.

•A revised proposal from Iwi and NZKS was provided to MPI in June 2019, including use of the proposed site at Mid Waitata.

•Any potential production benefit from relocation would be achieved in calendar year 2024 or beyond due to process timing.

Open Ocean Farming -NZKS has applied for its first open ocean farming consent comprising two farm sites, in the Marlborough region:

•The region has been named “Blue Endeavour” representing a step towards the long term sustainability of the industry.

•The RMA consenting process is underway and hearings are expected for June 2021.

•The earliest possible harvest from the region would be in the middle of the 2024 calendar year.

•Capital costs for the infrastructure associated with Blue Endeavour are estimated at ~$35m with some ability for this spend to be staged. This

investment would be expected to generate an eventual production volume of ~4,000 MT per site per 18 month cycle.

•Blue Endeavour is both a volume and unit value driver.

1H21 HALF YEAR RESULTS
18

APPENDICES

04

1H21 HALF YEAR RESULTS
APPENDIX – 1H21 RECONCILIATION BETWEEN GAAP

RESULTS AND PRO FORMA FINANCIALS

19

Statutory

Financial

Statements

Fair Value

Adjustments

IFRS 16 Lease

Adjustments

Pro Forma

Operating

Financial

Information

Revenue

82,27982,279

Cost of goods sold(78,350)31,018(789)(48,121)

19,999(19,999) -

Freight costs to market(9,585)(9,585)

Gross Profit14,34311,019(789)24,573

Other operating income454454

Overheads

Sales, marketing and advertising(6,732)(6,732)

Distribution overheads(2,679)(2,679)

Corporate expenses(5,110)(5,110)

Other expenses(2)(2)

27411,019(789)10,504

Depreciation and amortisation(5,003)740(4,262)

(4,729)11,019(48)6,241

Finance income44

Finance costs(1,147)117(1,030)

Net finance costs(1,143) - 117(1,026)

Profit / (loss) before Tax(5,872)11,019685,215

Income tax (expense) / credit1,549(3,085)(19)(1,556)

Net Profit / (loss) for the Year(4,323)7,933493,660

1H21

NZD 000s

Fair value gain / (loss) on biological transformation

EBITDA

EBIT

1H21 HALF YEAR RESULTS
APPENDIX – 1H20 RECONCILIATION BETWEEN GAAP

RESULTS AND PRO FORMA FINANCIALS

20

Statutory

Financial

Statements

Fair Value

Adjustments

IFRS 16 Lease

Adjustments

Pro Forma

Operating

Financial

Information

Revenue84,18984,189

Cost of goods sold(74,830)29,429(260)(45,661)

46,198(46,198) -

Freight costs to market(7,671)(7,671)

Gross Profit47,886(16,769)(260)30,857

Other operating income9494

Overheads

Sales, marketing and advertising(6,609)(86)(6,695)

Distribution overheads(2,214)(248)(2,462)

Corporate expenses(5,147)(113)(5,260)

Other expenses(64)(64)

33,946(16,769)(707)16,470

Depreciation and amortisation(4,431)656(3,775)

29,515(16,769)(51)12,695

Finance income99

Finance costs(734)92(642)

Net finance costs(725) - 92(633)

Profit / (loss) before Tax28,790(16,769)4112,062

Income tax (expense) / credit(8,024)4,695(11)(3,340)

Net Profit / (loss) for the Year20,766(12,074)308,722

EBIT

1H20

NZD 000s

Fair value gain / (loss) on biological transformation

EBITDA

1H21 HALF YEAR RESULTS
UNDERSTANDING OUR GAAP RESULTS

Our GAAP results are impacted by Fair Value gains or losses arising from the application of NZ IAS-41 Agriculture,

NZ IAS-2 Inventory and the classification of leases under NZ IFRS-16. The impact of these standards are explained below:

Fair Value under NZ IAS-41 Agriculture andNZ IAS-2 Inventory

When we record a change in biomass at sea, or where the expected future profit we realise on fish that we sell changes, thesestandards require

us to quantify and recognise the gain or loss in the current period. This applies to both biomass at sea and inventories of finished products.

Our Statement of Financial Position shows biological assets at their fair value, with 1H21 seeing a reduction in fair value as the value of biomass in the sea

was revalued downwards reflecting COVID driven margin compression especially in offshore sales. Pro Forma Operating Financial Performance removes

gains / losses associated with the application of these standards. The company will present Pro Forma results for future reporting periods on this basis.

NZ IFRS-16Leases

Under NZ IFRS-16 a lessee will no longer make a distinction between finance leases and operating leases; all (material) leases will be treatedas

finance leases.

In the statement of financial position we are therefore required to recognize the asset (or right to use the asset) and the liability for the lease, while in the

statement of profit and loss we recognize the interest cost and the depreciation of the leased asset instead of the operatinglease expenses. The

application of this standard increases EBITDA, assets and liabilities, however this impact is reversed in our Pro Forma results.

The impact of NZ IAS-41 Agriculture, NZ IAS-2 Inventory and NZ IFRS-16 Leases

21

1H21 HALF YEAR RESULTS
APPENDIX – GLOSSARY OF TERMS

1H20Financial results for the 6 months from 1 July 2019 to 31 December 2019

1H21Financial results for the 6 months from 1 July 2020 to 31 December 2020

CAGRCompounding annual growth rate

EBITDAEarnings before interest, tax, depreciation and amortisation

FCRFeed Conversion Ratio –the amount of feed (in kilograms) required to grow 1 kilogram of fish weight

G&GGilled and gutted. Note that all volumetric information presented is on a gilled and gutted basis unless otherwise stated

GAAPGenerally Accepted Accounting Practice

Mortality / Mortality RateThe percentage mortality of salmon in seawater, calculated as the biomass of salmon mortalities in kg divided by the growth of salmon in kg

MTMetric tonnes

NPATNet profit after tax, also reported as net profit for the period in our published financial results

NZKSNew Zealand King Salmon

Pro Forma Operating EBITDA

Pro Forma Operating EBITDA refers to earnings before interest, tax, depreciation, amortisation after allowing for pro forma adjustments as described in

the Appendix to this document. Pro Forma Operating EBITDA is a non-GAAP profit measure

Upwelling System

A system that allows dense cooler water to be moved towards the ocean surface, displacing the warmer water and increasing water flow.

22

1H21 HALF YEAR RESULTS
23

DISCLAIMER

The information in this presentation has been prepared by New Zealand King Salmon Investments Limited with due care and attention. However, neither New Zealand King Salmon

Investments Limited nor any of its directors, employees, shareholders nor any other person shall have any liability whatsoever to any person for any loss (including, without

limitation, arising from any fault or negligence) arising from this presentation or any information supplied in connection with it.

This presentation may contain projections or forward-looking statements regarding a variety of items. Such projections or forward-looking statements are based on current

expectations, estimates and assumptions and are subject to a number of risks, uncertainties and assumptions. There is no assurance that results contemplated in any projections

and forward-looking statements in this presentation will be realised. Actual results may differ materially from those projected in this presentation. No person is under any obligation

to update this presentation at any time after its release to you or to provide you with further information about New ZealandKi ng Salmon Investments Limited.

Our results are reported under NZ IFRS. This presentation includes non-GAAP financial measures which are not prepared in accordance with NZ IFRS. The non-GAAP financial

measures used in this presentation include:

•EBITDA. We calculate EBITDA by adding back (or deducting) depreciation, amortisation, finance expense / (income), and taxation expense to net earnings / (loss) from

continuing operations.

•EBIT. We calculate EBIT by adding back (or deducting) finance expense / (income), and taxation expense to net earnings / (loss) from continuing operations.

•Pro Forma Operating EBITDA refers to earnings before interest, tax, depreciation and amortisation after allowing for pro forma adjustments as described in the Appendix to this

document.

We believe that these non-GAAP financial measures provide useful information to readers to assist in the understanding of our financial performance, financial position or returns,

but that they should not be viewed in isolation, nor considered as a substitute for measures reported in accordance with NZ IFRS. Non-GAAP financial measures may not be

comparable to similarly titled amounts reported by other companies.

Forward-looking statements are subject to any material adverse events, significant one-off expenses or other unforeseeable circumstances.

The information in this presentation is of a general nature and does not constitute financial product advice, investment advice or any recommendation. Nothing in this presentation

constitutes legal, financial, tax or other advice.

1H21 HALF YEAR FINANCIAL RESULTS

---

1H21
NEW ZEALAND KING SALMON INVESTMENTS LIMITED AND

SUBSIDIARIES

INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

1

CONTENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

Page

Corporate Information

3

Consolidated statement of comprehensive income

4

Consolidated statement of financial position

5

Consolidated statement of changes in equity

6

Consolidated statement of cash flows

7

Notes to the consolidated financial statements

8 - 14

2

NEW ZEALAND KING SALMON INVESTMENTS LIMITED AND SUBSIDIARIES
CORPORATE DIRECTORY

BOARD OF DIRECTORSBANKERSNEW ZEALAND KING SALMON

INVESTMENTS LIMITED

John William Dudley Ryder The Bank of New ZealandTicker: NZK

Independent Non-Executive ChairmanDeloitte CentreListed on the NZX Main Board and

Grantley Bruce RosewarneLevel 6, 80 Queen Streetas a foreign Exempt Listing on the

Chief Executive Officer and Managing DirectorAucklandASX

Jack Lee PorusNew ZealandNZ Company number: 2161790

Non-Executive Director

Paul James SteereAUDITORRegistered Office

Independent Non-Executive Director93 Beatty Street

Lai Po SingErnst & Young (EY)Annesbrook

Non-Executive DirectorLevel 4, 93 Cambridge TerraceNelson

Chiong Yong TiongChristchurch New Zealand

Non-Executive DirectorNew Zealand

Catriona MacleodPostal Address

Independent Non-Executive DirectorLAWYERSPO Box 1180 Nelson 7040

New Zealand

Audit and Finance CommitteeChapman Tripp

Paul Steere (Chair)Level 35, 23 Albert StreetTelephone

John RyderAuckland+64 3 548 5714

Jack Porus (Appointed 26 August 2020)New Zealand

Website

Nominations and Remuneration CommitteeGascoigne Wickswww.kingsalmon.co.nz

Paul Steere (Chair)79 High Street

Jack PorusBlenheimInvestor Relations

New Zealandinvestor@kingsalmon.co.nz

Health, Safety and Risk Committee

Catriona Macleod (Chair)Duncan Cotterill

Chiong Yong Tiong197 Bridge StreetSHARE REGISTRY

NelsonComputershare Investor

New ZealandServices Limited

Level 2, 152 Hurstmere Road

Takapuna

Auckland 0622

New Zealand

+64 9 488 8777

enquiry@computershare.co.nz

Computershare Investor

Services Pty Limited

Yarra Fall

452 Johnston Street

Abbotsford VIC 3001

Australia

+61 3 9415 4083

enquiry@computershare.co.nz

3

INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Note$000$000

Revenue from contracts with customers482,279 84,189

Cost of goods sold including fair value uplift at point of harvest(78,350) (74,830)

Fair value gain on biological transformation719,999 46,198

Freight costs to market(9,585) (7,671)

Gross profit

14,343 47,886

Other income454 94

Sales, marketing and advertising expenses(6,732) (6,609)

Distribution overheads(2,679) (2,213)

Corporate expenses(5,110) (5,148)

Other expenses(2) (64)

Earnings before interest, tax, depreciation and amortisation

274 33,946

Depreciation and amortisation expense(5,003) (4,431)

Finance income4 9

Finance expenses(1,147) (734)

(Loss) / Profit before tax(5,872) 28,790

Income tax credit / (expense)1,549 (8,024)

(Loss) / Profit after tax(4,323) 20,766

Other comprehensive income

Exchange differences on translation of foreign operations(596) 4

Movement on cash flow hedges20,737 2,821

Income tax effect of movement on cash flow hedges

(5,802) (790)

Share based payment expense85 164

Net other comprehensive income

14,424 2,199

Total comprehensive income10,101 22,965

UNAUDITEDUNAUDITED

Earnings per share31 Dec 202031 Dec 2019

Basic earnings per share

5

(0.03)$ 0.15$

Diluted earnings per share

5

(0.03)$ 0.15$

Other comprehensive income to be reclassified to profit

or loss in subsequent periods:

The above interim consolidated statement of comprehensive income should be read in conjunction with the accompanying notes.

4

INTERIM CONSOLIDATED STATEMENT OF FINANCIA L POSITION
AS AT 31 DECEMBER 2020

UNAUDITEDAUDITED

31 Dec 202030 Jun 2020

ASSETSNot e$000$000

Current assets

Cash and cash equivalents5,5817,115

Trade and other receiv ables14,75812,777

Inventories645,78335,612

Biological assets769,67781,784

Deriv ativ e financial assets105,734907

Total current assets

141,533138,195

Non-current assets

Property, plant and equipment60,90860,481

Biological assets718,22610,594

Deriv ativ e financial assets1020,5309,120

Deferred tax asset2,0443,303

Intangible assets9,0308,655

Goodwil l39,25539,255

Right-of-use assets87,0394,581

Total non-current asse

ts

157,032135,989

TOTAL ASSETS

298,565274,184

LIABILITIES

Current liabi lit ies

Trade and other payables17,46914,847

Employee benefit s3,3772,884

Borrowings92,6141,132

Lease li abilit ies1,5861,347

Ot her financial li abilit ies13233149

Deriv ativ e financial li abilit ies101,6963,868

Taxation payable5,3403,866

Total current liabi lit ies

32,31528,093

Non-current liabi lit ies

Employee benefit s711558

Borrowings946,00037,000

Lease li abilit ies5,5443,258

Deferred tax li abilit ies19,36918,436

Deriv ativ e financial li abilit ies102112,525

Total non-current liabi lit ies

71,83561,777

TOTAL LIABILITIES

104,15089,870

NET ASSETS

194,415184,314

EQUITY

Share capital12122,606122,606

Reserves17,4022,978

Retained earnings54,40758,730

TOTAL EQUITY

194,415184,314

Net tangibl e assets per share

Net tangible assets per share1.04$ 0.96$

Dire ctorDire ctor

23 February 202123 February 2021

The above int erim consoli dated statement of financial posit ion should be read in conjunction wit h the accompanying notes.

For and on behalf of the Board, who aut horised the issue of these financial statements on 23 February 2021

5

INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

Share

Capital

Foreign

Currency

Translation

Reserve

Hedge

Reserve

Share Based

Payment

Reserve

Retained

Earnings

Total

Equity

UNAUDITED$000$000$000$000$000$000

Balance as at 1 July 2020

122,606(485) 2,58787658,730184,314

Profit / (loss) for the period- -

-

- (4,323) (4,323)

Other comprehensive income/(loss)- (596) 14,9358514,424

Total comprehensive income/(loss) for the period

- (596) 14,93585(4,323) 10,101

Dividends paid - ordinary- - - - - -

Balance as at 31 December 2020122,606(1,081) 17,52296154,407194,415

UNAUDITED

Balance as at 1 July 2019

122,595(639) (1,391) 57547,612168,752

Profit for the period- - - - 20,76620,766

Other comprehensive income/(loss)- 42,0311642,199

Total comprehensive income/(loss) for the period

- 42,03116420,76622,965

Dividends paid - ordinary- - - - (4,284) (4,284)

Employee share scheme loans repaid8- - - - 8

Balance as at 31 December 2019122,603(635) 64073964,094187,441

The above interim consolidated statement of changes in equity should be read in conjunction with the accompanying notes.

6

INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

$000$000

Operating activities

Receipts from customers80,067 81,016

Payments to suppliers(64,258) (52,820)

Payments to employees(21,131) (21,132)

Dividend received

- 43

Interest received4 9

Interest paid(773) (553)

Other income received- 308

Income tax paid(588) (4,831)

Net cash flows (to) / from operating activities

(6,679) 2,041

Investing activities

Proceeds from sale of property, plant and equipment- 3

Purchase of property, plant and equipment(4,399) (10,409)

Purchase of intangible assets(707) (28)

Net cash flow (to) / from investing activities

(5,106) (10,434)

Financing activities

Proceeds from borrowings10,482 12,000

Government grants received403 15

Payment of lease liabilities(634) (615)

Employee share scheme loans repaid- 8

Dividends paid- (4,284)

Net cash flows (to) / from financing activities

10,251 7,125

Net increase / (decrease) in cash and cash equivalents

(1,534) (1,269)

Cash and cash equivalents at 1 July

7,115 6,231

Cash and cash equivalents at 31 December

5,581 4,962

The above interim consolidated statement of cash flows should be read in conjunction with the accompanying notes.

7

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

1.CORPORATE INFORMATION

The Group has changed its balance date to 31 January following a Board resolution on 2 November 2020.

2.BASIS OF PREPARATION

a.Statement of compliance

b.Basis of measurement

c.Significant accounting judgements, estimates and assumptions

d.Covid-19

3.SEASONALITY

The interim financial statements of New Zealand King Salmon Investments Limited (the Company) and its subsidiaries (together the

Group) for the six months ended 31 December 2020 were authorised by the Directors on 23 February 2021.

Management have applied the same principles and used the same key sources of estimation in the preparation of the interim

financial statements as those applied in the consolidated financial statements for the year ended 30 June 2020.

New Zealand King Salmon Investments Limited is a profit-orientated company incorporated and domiciled in New Zealand. The

Company is registered under the Companies Act 1993 and listed on the NZX Main Board ("NZX") and the Australian Securities

Exchange ("ASX"). The Company is an FMC reporting entity under the Financial Markets Conduct Act 2013.

The interim consolidated financial statements are for the six months ended 31 December 2020 and have been prepared in

accordance with NZ GAAP.

The interim consolidated financial statements for the six months ended 31 December 2020 have been prepared in accordance with

NZ IAS 34 - Interim Financial Reporting and IAS 34 Interim Financial Reporting, and should be read in conjunction with the annual

financial statements as at 30 June 2020 which were prepared in accordance with NZ IFRS and IFRS.

The accounting policies adopted in the interim financial statements are consistent with those applied in the annual financial

statements as at 30 June 2020.

The interim consolidated financial statements for the six months ended 31 December 2020 are unaudited. Comparative information

for the interim consolidated statement of financial position is at 30 June 2020 and is audited. Comparative information for the interim

consolidated statement of comprehensive income, statement of interim consolidated changes in equity and interim consolidated

statement of cash flows is for the comparative six month period and is unaudited.

The Group is principally engaged in the farming, processing and sale of premium salmon products.

The consolidated financial statements are presented in New Zealand dollars and all values are rounded to the nearest thousand

($000), except when otherwise indicated.

Due to the rapid impact of the pandemic virus Covid-19 impacting significantly on finished stock holdings, the Group estimates the

net realisable value of inventory for obsolescence and unmarketable items at the end of the reporting period and then writes down

the cost of inventories to estimated net realisable value. The estimated net realisable value of the inventory is mainly determined

based on assumptions of future demand within a specific time horizon.

The Group's business is not considered to be highly seasonal. Sales and related costs vary from month to month with overall

variation considered to be immaterial. Mortality rates are typically highest in the January to April period due to higher water

temperatures at that time. This does impact on month to month profitability.

8

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

4.SEGMENT INFORMATION

Segment results

UNAUDITEDUNAUDITED

20202019

$000$000

Revenue82,27984,189

Segment EBITDA27433,946

UNAUDITEDUNAUDITED

Segment profit reconciles to profit before income tax as follows:

20202019

$000$000

Segment EBITDA27433,946

Depreciation, amortisation and impairment(5,003) (4,431)

Net finance costs(1,143) (725)

Group profit / (loss) before tax(5,872) 28,790

5.EARNINGS PER SHARE

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Earnings per share$000$000

Profit / (loss) attributable to ordinary equity holders (4,323) 20,766

# of Shares# of Shares

000000

Weighted average number of ordinary shares for diluted earnings per share138,986138,697

Basic earnings per share(0.03)$ 0.15$

Diluted earnings per share(0.03)$ 0.15$

6.INVENTORIES

UNAUDITEDAUDITED

31 Dec 202030 Jun 2020

Inventories$000$000

Raw materials13,0919,184

Work in progress5931,192

Finished goods32,09925,236

Total inventories45,78335,612

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Amount of inventories recognised as an expense in the statement of comprehensive income$000$000

Cost of inventories recognised as an expense69,911 74,036

Movement in net realisable value of inventory provision8,439 794

Total cost of goods sold including fair value uplift at point of harvest78,350 74,830

7.BIOLOGICAL ASSETS

UNAUDITED

Cost Fair valueTotal

Biological assets$000$000$000

As at 1 July 2020

53,70438,67492,378

Increase due to biological transformation

1

44,69724,43569,132

Decrease due to harvest

2

(34,444) (29,649) (64,093)

Decrease due to mortality

3

(5,077) - (5,077)

Changes in fair value

4

- (4,437) (4,437)

As at 31 December 2020

58,88029,02387,903

1

Biological transformation fair value is impacted by volume increases (net of mortalities) and fish size at reporting date relative to the target harvest weight of 4 kgs (proportional recognition).

2

Harvested fair value is included under cost of goods sold in the statement of comprehensive income and is calculated by multiplying the current years harvest (biomass) by the prior

years expected gross margin per kg (recognised at 100%).

3

Mortality cost is expensed directly to the statement of comprehensive income in the period which it occurs.

4

Changes in fair value are impacted by movements in margin primarily being changes in sales price and costs to sell (fish cost, harvest, processing and freight to market).

Basic earnings per share amounts are calculated by dividing the profit for the year attributable to shareholders of the Company by the weighted average number of

ordinary shares on issue during the year. Diluted earnings per share assumes conversion of all potential ordinary shares in determining the weighted average number

of ordinary shares on issue.

For management purposes, the Group is organised into one business unit. The operating results of the whole business are monitored for the purpose of making

decisions about resource allocation and performance assessment.

Segment performance - Refer also Note 14 for detail of disaggregation of revenue by brand and geographical area.

The cost of inventories recognised as an expense for the period ended 31 December 2020 includes a fair value uplift at point of harvest of $13,445k (31 December

2019: $29,276k).

The Group has three hatcheries in the South Island and nine operational marine salmon farms in the Marlborough Sounds. The fish livestock typically grow for up to 31

months before harvest.

In FY20, the Group reviewed its operating segments and considers that there is only one operating segment. This is based on management’s on going review of the

business and operations and as crystallised by the pandemic Covid-19 virus. The strategy is to focus on branded, premium priced and differentiated sales in all

markets / channels / customers so as to maximise longer term sales and overall margins. The group has executed this strategy during the COVID-19 situation,

resulting in product being deployed to certain other markets, channels and customers.

Prior year comparatives have been restated to respond to the change to a single operating segment.

9

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

BIOLOGICAL ASSETS (CONTINUED)

UNAUDITED

Cost Fair valueTotal

Biological assets$000$000$000

As at 1 July 201944,37033,86178,231

Increase due to biological transformation

1

43,50546,07289,577

Decrease due to harvest

2

(32,409) (30,252) (62,661)

Decrease due to mortality

3

(2,166) - (2,166)

Changes in fair value

4

- 126126

As at 31 December 2019

53,30049,807103,107

AUDITED

Cost Fair valueTotal

Biological assets$000$000$000

As at 1 July 201944,37033,86278,232

Increase due to biological transformation

1

84,12667,399151,525

Decrease due to harvest

2

(63,144) (59,312) (122,456)

Decrease due to mortality

3

(11,648) - (11,648)

Changes in fair value

4

(3,275) (3,275)

As at 30 June 2020

53,70438,67492,378

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Fair value gain / (loss) recognised in profit and loss$000$000

Gain arising from growth of biological assets24,43646,072

Movement in fair value of biological assets(4,437) 126

Total fair value gain on biological transformation19,999 46,198

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Harvested biomasstonnestonnes

Total live weight harvested for the period 4,7164,252

UNAUDITEDAUDITED

31 Dec 202030 Jun 2020

Estimated closing biomasstonnestonnes

Closing fresh water stocks154158

Closing seawater stocks6,7906,136

Total estimated closing biomass live weight 6,9446,294

Fair value measurement

Fair value risk and sensitivity

The Group is exposed to financial risks relating to the production of salmon stock including increasing climate change volatility, climatic events, disease and

contamination of water space.

The estimated unrealised fair value gain from cost at 31 December 2020 decreased from the prior year end estimation due to expected increased costs of working and

selling due to Covid-19 and a change in product mix to incorporate a proportion of lower value frozen product sales. Core sales volumes are expected to return to pre

Covid-19 levels during the first six months of calendar year 2021. Changes in these assumptions will impact the fair value calculation. The realised profit which is

achieved on the sale of inventory will differ from the calculations of fair value of biological assets because of changes in key factors such as the final market

destinations and product mix of inventory sold, changes in price, foreign exchange rates, harvest weight, growth rates, mortality, cost levels and differences in

harvested fish quality.

Leaving all other variables constant a 15% increase/decrease in average future sales prices would have increased/decreased the fair value of biological assets on

hand and profit before tax by $17.4m (30 June 2020: 15% increase / decrease $19.4m) (excludes the impact of finished goods), while a 15.0% increase/decrease in

estimated future harvest volume would increase/decrease the fair value of biological assets on hand and profit before tax by $4.3m (30 June 2020: 15% increase /

decrease $5.8m).

The valuation of biological assets is carried out separately for each site at a brood and strategy level. Estimated actual cost up to the date of harvest per site is used to

measure the expected margin at the time the fish is defined as ready for harvest, being 4.0kg live weight. Selling price is estimated at balance date based on the most

relevant future market price at expected harvest date. The expected gross margin is recognised proportionately based on average biomass at reporting date. Fair

value measurement commences at the date of transfer to sea water as this is considered the point at which the fish commence their grow out cycle.

The Group seeks to produce and market the highest quality salmon products. Extensive monitoring and benchmarking is carried out to provide optimum conditions and

diets to maximise fish performance during the grow out cycle. Sales are maintained in a range of brands, products and markets to maximise returns from the quality

mix of fish harvested. The Group has insurance to cover some of the risks relating to the livestock.

Measurement of fair value is performed using a fair value model. The method of valuation therefore falls into level 3 of the fair value hierarchy as the inputs are

unobservable inputs.

A 15% increase/decrease in estimated costs to sell would decrease/increase the fair value of biological assets on hand at balance date and profit before tax by $13.1m

(30 June 2020: 15% increase / decrease $13.6m). Changes in fish health and environmental factors may affect the quality of harvested fish, which may be reflected in

realised profit via both achieved sales price and production costs.

10

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

8.RIGHT-OF-USE ASSETS

Land &

Building

Motor

Vehicles

Plant &

Equipment

UNAUDITED

31 Dec 2020

AUDITED

30 Jun 2020

UNAUDITED000000000$000$000

Carring amount at 1 July 20203,1333541,0944,5814,446

Additions2,232139432,4141,304

Remeasurement88613- 899268

Depreciation for the period(494) (128) (233) (855) (1,437)

Carrying amount as at 31 December or 30 June

5,7573789047,0394,581

Cost 6,9076761,5979,1806,018

Accumulated Depreciation(1,150) (298) (693) (2,141) (1,437)

Carrying amount as at 31 December or 30 June5,7573789047,0394,581

9.INTEREST BEARING LOANS AND BORROWINGS

UNAUDITEDAUDITED

31 Dec 202030 Jun 2020

Current interest bearing loans and borrowings$000$000

Secured bank loans8797

Other borrowings2,5271,035

Total current interest bearing loans and borrowings

2,6141,132

Non-current interest bearing loans and borrowings

Secured bank loans46,00037,000

Total non-current interest bearing loans and borrowings

46,00037,000

10.FAIR VALUE OF FINANCIAL INSTRUMENTS

The following financial instruments of the Group are carried at fair value:UNAUDITEDAUDITED

31 Dec 202030 Jun 2020

Current derivative financial assets$000$000

Forward exchange contracts4,780599

Foreign exchange options954308

Total Current derivative financial assets

5,734907

Non-current derivative financial assets

Forward exchange contracts19,5518,361

Foreign exchange options979759

Total Non-current derivative financial assets

20,5309,120

Current derivative financial liabilities

Forward exchange contracts1301,684

Foreign exchange options51435

Interest rate swaps1,5151,749

Total Current derivative financial liabilities

1,6963,868

Non-current derivative financial liabilities

Forward exchange contracts321,642

Foreign exchange options179883

Interest rate swaps- -

Total non-current derivative financial liabilities

2112,525

Valuation methods

Level 1: Quoted prices in active markets for identical assets or liabilities that the entity can access at the measurement date

Level 3: Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs)

All derivative financial instruments for which a fair value is recognised have been categorised within level 2 of the fair value hierarchy. Industry experts have provided

the fair values for all derivatives based on an industry standard model. There were no transfers between Level 1 and Level 2 during the period ended 31 December

2020

The carrying value of the BNZ loan drawing of $46M is considered a reasonable approximation of its fair value due to the short term maturities of the drawings. The

Group has the discretion to roll these short term drawings out within facility A ($20m) to 18 Oct 2022 and facility B ($20m) to 18 Oct 2023.

Financial instruments have been categorised into the following hierarchy and valued according to the following definitions, based on the lowest level input that is

significant to the fair value measurement as a whole:

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly (i.e. as prices) or indirectly (i.e. derived from

prices)

The carrying value of cash and short term deposits, trade receivables, trade payables and other current liabilities is considered a reasonable approximation to their fair

value due to the short term maturities of these instruments.

The Company has facilities with BNZ for $60m, secured by a general security deed over the assets of the Group. The expiry date of facility A of $20m is 18 October

2022, facility B of $20m expires on 18 October 2023, and facility C of $20m expires on 18 October 2024. At balance date $20m of facility A was drawn, $20m of facility

B was drawn and $1m of facility C was drawn (30 June 2020 total: $37m). Subsequent to 30 June 2020 balance date, the financial covenants relating to interest

coverage and leverage ratios have been amended and are in place until 30 June 2021, and facility A extended to 18 October 2022. The Company also secured a

Business Finance Scheme Loan via BNZ for $5m that arose from the Government providing financial assistance following the pandemic virus Covid-19. At balance

date the Business Finance Scheme loan was fully drawn at $5m.

11

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

11.COMMITMENTS AND CONTINGENCIES

UNAUDITED

Capital commitments

Contingencies

Guarantees

12.CAPITAL AND RESERVES

UNAUDITEDAUDITED

Share capital31 Dec 202030 Jun 2020

Issued shares000000

Ordinary shares138,986 138,986

Total issued shares

138,986 138,986

UNAUDITEDAUDITEDUNAUDITEDAUDITED

31 Dec 202030 Jun 202031 Dec 202030 Jun 2020

Movement in ordinary share capital000000$000$000

As at 1 July138,986 138,571122,606122,595

Share issue for employee share scheme- 415-

Share issue recognised on repayment of employee loans- - - 11

As at 31 December or 30 June

138,986 138,986122,606122,606

Shares held as treasury stock1864

Total shares outstanding at 31 December or 30 June

138,800138,982

Reserves

Foreign currency translation reserve

Hedge reserve

Retained earnings

Share based payment reserve

000000000000000000

LTI 201729/09/2017*295- - (8) (287) -

LTI 201827/09/2018300- - (7) - 293

LTI 20195/11/2019451- - (181) - 270

Total share scheme

1,046 - - (196)(287)563

Share allocation price for share schemes

LTI 2017$1.22$1.77- -

LTI 2018$1.30$1.95$2.78-

LTI 2019$1.41$2.13- $2.20

Share schemeGrant date

30 June 2020

shares not

yet vested

New shares

issued to

custodian

Shares

forfeited to

treasury stockShares vested

31 December

2020 shares

not yet vested

* Fully vested in current year

Shares

allocated from

treasury stock

The estimated value of share options was determined using the Black-Scholes pricing calculator and is being amortised over the restrictive periods. The option cost is

treated as an employee expense with the corresponding credit included in the share based payment reserve. The inputs into the option pricing valuation model are the

share price of the Group at time of allocation and the compounded risk free interest rate.

Share scheme

The Group has entered into agreements to purchase plant and equipment. As at 31 December 2020 the total commitment is $1,653k (30 June 2020: $2,598k).

The share based payment reserve relates to one long term incentive (LTI) scheme and two employee share ownership schemes. All of these schemes involve the

Company making interest-free limited recourse loans to selected personnel to acquire shares in the Company. The employees must remain in employment for the

duration of the vesting or escrow periods before the employees receive the full benefit of share ownership subsequent to repayment of the loan balance remaining at

time of vesting.

The hedge reserve represents the unrealised gains and losses on interest rate swaps and foreign currency forward contracts that the Group has taken out in order to

mitigate interest rate and foreign currency risks, net of deferred tax.

Share Capital# of Shares

Employee

Group 4

The Group has a contingent liability at 31 December 2020 of $837k in respect of a fish transport contract requiring the Group to purchase three bulk tankers (including

modifications made in 2018 and 2020), should the fish transport contract be terminated early (30 June 2020: $784k).

Ordinary shares are fully paid with no par value. Each ordinary share has an equal right to vote, to participate in dividends, and to share in any surplus on winding up of

the Company. No dividend was declared nor paid during the period ended 31 December 2020 due to impact of the virus Covid-19, (31 December 2019: $0.02 paid on

20 March 2020).

The foreign currency translation reserve is used to record exchange difference arising from the translation of the financial statements of the foreign subsidiary.

Employee

Group 1

Employee

Group 2

Employee

Group 3

The group has three guarantee facilities at 31 December 2020 totalling $115k (30 June 2020: $115k).

Retained earnings represents the profits retained in the business.

12

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

13.RELATED PARTY DISCLOSURES

Subsidiaries

New Zealand King Salmon Investments Limited has the following trading subsidiaries.

SubsidiaryCountry of Incorporation

The New Zealand King Salmon Co. LimitedNew Zealand100%

New Zealand King Salmon Exports LimitedNew Zealand100%

The New Zealand King Salmon Pty LimitedAustralia100%

New Zealand King Salmon USA IncorporatedUnited States of America100%

Transactions with related parties

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Related party payments$000$000

Good and services purchased from other related parties266196

Total related party payments

266196

Related party sales

Goods and services sold to related parties(29) (1,975)

Total related party sales

(29) (1,975)

Sales to and purchases from related parties are made in arm's length transactions, both at normal market prices and on normal commercial terms.

UNAUDITEDAUDITED

Amounts owing to related parties

31 Dec 202030 Jun 2020

Current amounts owing to related parties$000$000

Other amounts owing to related parties233149

Total current amounts owing to related parties

233149

UNAUDITEDAUDITED

31 Dec 202030 Jun 2020

Amounts owing by related parties$000$000

Amounts owing by related parties37

Total amounts owing by related parties

37

UNAUDITEDUNAUDITED

Compensation of key management personnel of the Group

31 Dec 202031 Dec 2019

Key management personnel compensation$000$000

Short-term employee benefits996893

Share based payment expense85107

Post employment pension and medical benefits2848

Total key management personnel compensation

1,1091,048

At balance date Oregon Group Limited owned 40.02% (30 June 2020: 40.02%) and China Resources Ng Fung Limited owned 9.93% (30 June 2020: 9.93%) of the

shares in New Zealand King Salmon Investments Limited.

Sales to and purchases from related parties are made in arm's length transactions both at normal market prices and on normal commercial terms. The following

provides the total amount of transactions that were entered into with related parties for the relevant financial year:

The principal activity of The New Zealand King Salmon Co. Ltd is the farming and processing of salmon. The activity of New Zealand King Salmon Exports Limited,

The New Zealand King Salmon Pty Limited, and New Zealand King Salmon USA Incorporated is the distribution of salmon.

Equity Interest

13

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

14.DISAGGREGATION OF REVENUE

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Revenue by Product Group$000$000

Whole Fish

39,10941,989

Fillets, Steaks & Portions

16,12717,673

Wood Roasted

7,6946,478

Cold Smoked

14,46814,384

Other

4,8813,665

Total

82,27984,189

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Revenue by Brand$000$000

Ōra King30,24834,832

New Zealand King Salmon28,16329,724

Regal17,43514,229

Southern Ocean5,1524,769

Omega Plus1,281635

Total

82,279 84,189

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Revenue by Market$000$000

New Zealand35,76336,102

North America31,46030,772

Australia5,5115,263

Japan3,0933,060

China9322,234

Europe2,6391,862

Other2,8814,896

Total revenue

82,27984,189

15.EVENTS AFTER BALANCE DATE

UNAUDITEDUNAUDITED

31 Dec 202031 Dec 2019

Dividends declared after balance date:$000$000

- 2,780

- 2,780

The Group does not consider it practicable to provide a quantitative or qualitative estimate of the potential impact of Covid-19 outbreak, or any future outbreaks at this

time. The build-up of finished goods inventories follows a strategic decision to temporarily hold inventories until sales markets return to pre Covid-19 levels in up

coming months when inventories will be sold down. The Group continues its farming and processing operations under Level 1, and continues to pursue its strategy of

marketing its branded products across the range of customers, and markets and products. In the event of a Level 4 lockdown the Group anticipates being able to

continue to operate as an essential industry.

Sales net of settlement discounts to two major customers for the period ended 31 December 2020 accounted for $19,951k or 24% of total gross revenue, (31

December 2019 one major customer accounted for $9,619k or 11% of total gross revenue).

No interim dividend was declared in respect of the 6 months ended 31 December 2020, (31 December 2019: a fully imputed interim dividend of 2 cents was approved

on 26 February 2020 and paid 20 March 2020).

Interim dividend

14

---

Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)




93 Beatty Street, Tahunanui, Nelson 7011, New Zealand

+64 3 548 5714


contact@kingsalmon.co.nz


www.kingsalmon.co.nz


Results for announcement to the market

Name of issuer New Zealand King Salmon Investments Limited

Reporting Period 6 months to 31 December 2020

Previous Reporting Period 6 months to 31 December 2019

Currency NZD

NZ$ Amount (000s) Percentage change

Revenue from continuing

operations

$82,279 (2.3) %

Total Revenue $82,279 (2.3) %

Net profit/(loss) from

continuing operations

($4,323) (120.8)%

Total net profit/(loss) ($4,323) (120.8)%

Interim/Final Dividend

Amount per Quoted Equity

Security

$ nil

Imputed amount per Quoted

Equity Security

$ nil

Record Date N/A

Dividend Payment Date N/A

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security

$1.04 $0.96

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

No interim dividend was declared in respect of the 6 months

ended 31 December 2020.

Authority for this announcement

Name of person


authorised

to make this announcement

Andrew Clark

Contact person for this

announcement

Andrew Clark

Contact phone number

+64 21 471 953


Contact email address

Andrew.clark@kingsalmon.co.nz


Date of release through MAP


24 February 2021


Unaudited financial statements accompany this announcement.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.